イリノイ州における非筋層浸潤性膀胱癌の臨床試験
イリノイ州内の拠点で、非筋層浸潤性膀胱癌に関する11件の研究が参加者を募集しています。
イリノイ州内の都市
公式研究テキスト（英語）
Testing the Addition of an Anti-Cancer Drug, Gemcitabine, to Usual Treatment (BCG Alone) in People Whose Non-Muscle Invasive Bladder Cancer (NMIBC) Came Back After Prior BCG Therapy
- Northwestern University, Chicago
- University of Illinois, Chicago
- Loyola University Medical Center, Maywood
- 他1件
被験者募集中第3相
18歳以上 · 全性別 · 2026/10/02更新 · NCT07000084A Clinical Study of Intismeran Autogene (V940) and BCG in People With Bladder Cancer (V940-011/INTerpath-011)
- Associated Urological Specialists - Chicago Ridge ( Site 0139), Chicago Ridge
被験者募集中第2相
18歳以上 · 全性別 · 2026/10/01更新 · NCT06833073Efficacy and Safety of TYRA-300 in Participants With FGFR3 Altered Low Grade, Intermediate Risk Non-Muscle Invasive Bladder Cancer
- Associated Urological Specialists, Chicago Ridge
- Duly Health and Care, Lisle
被験者募集中第2相
18歳以上 · 全性別 · 2026/09/29更新 · NCT06995677A Study to Evaluate TAR-210 Versus Intravesical Chemotherapy Treatment in Participants With High Risk Non-Muscle-Invasive Bladder Cancer
- Associated Urological Specialists, Chicago Ridge
- UroPartners, Glenview
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/28更新 · NCT06919965A Study to Learn About the Study Medicine PF-08052667 in People With Bladder Cancer
- Northwestern Memorial Hospital, Chicago
- Northwestern University - Feinberg School of Medicine, Chicago
被験者募集中第1相
18歳以上 · 全性別 · 2026/09/28更新 · NCT07206225A Study to Assess Real-World Use and Outcomes of TAR-200 for Participants With Non-Muscle Invasive Bladder Cancer (NMIBC) in the United States
- Associated Urological Specialists, Chicago Ridge
被験者募集中観察研究
18歳以上 · 全性別 · 2026/09/25更新 · NCT07309445A Clinical Study of Sacituzumab Tirumotecan (MK-2870) in Patients With Bladder Cancer (MK-2870-027)
- Northwestern University ( Site 0051), Chicago
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/08/28更新 · NCT06637423Safety and Efficacy Study of Intravesical Instillation of TARA-002 in Adults With High-grade Non-muscle Invasive Bladder Cancer
- Comprehensive Urologic Care, Lake Barrington
被験者募集中第2相
18歳以上 · 全性別 · 2026/08/24更新 · NCT05951179FORAGER-1: A Study of Vepugratinib (LY3866288; LOXO-435) in Participants With Cancer With a Change in a Gene Called FGFR3
- The University of Chicago Medical Center (UCMC), Chicago
被験者募集中第1相
18歳以上 · 全性別 · 2026/08/20更新 · NCT05614739Blue Light Cystoscopy With Cysview® Registry
- Northwestern University, Chicago
- Northshore University Health System, Evanston
被験者募集中観察研究
18歳以上 · 全性別 · 2025/12/18更新 · NCT02660645Intravesical Photodynamic Therapy ("PDT") in BCG-Unresponsive/Intolerant Non-Muscle Invasive Bladder Cancer ("NMIBC") Patients
- Site 02-012 - University of Chicago, Chicago
被験者募集中第2相
18歳以上 · 全性別 · 2025/11/24更新 · NCT03945162ClinicalTrials.govより、2026/10/06時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。